Essential fatty acid deficiency in patients receiving home parenteral nutrition
- PMID: 9665106
- DOI: 10.1093/ajcn/68.1.126
Essential fatty acid deficiency in patients receiving home parenteral nutrition
Abstract
Home parenteral nutrition (HPN), initiated in patients with severe malabsorption or decreased oral intake, may exhaust stores of essential fatty acids and cause clinical manifestations, mainly dermatitis. Plasma fatty acid profiles were measured by gas-liquid chromatography in 37 healthy control subjects and 56 patients receiving HPN. The concentration (% by wt of total fatty acids) of 18:2n-6 was 22.8% and 11.4% (P < 0.001), whereas 18:3n-3 was 0.2% and 0.1% (P < 0.01) in control subjects and patients, respectively. Reduced small bowel length was associated with aggravated biochemical signs of essential fatty acid deficiency (EFAD). The effect of parenteral lipid on plasma phospholipids was evaluated in subgroups of patients. In patients with > 200 cm of remaining small intestine, those receiving parenteral lipids had only minor changes in the fatty acids of plasma phospholipids compared with patients not receiving parenteral lipids. In patients with < 100 cm of remaining small intestine, those receiving parenteral lipids had increased concentrations of total n-6 fatty acids; however, these did not reach the concentrations in control subjects. No differences were seen in n-3 fatty acids. Twenty-five of the 56 patients receiving HPN reported skin problems. No differences were found in plasma phospholipid fatty acids, Holman index, or the supply of parenteral lipids between patients with and without skin problems. Patients receiving HPN had biochemical signs of EFAD. Parenteral lipids did not increase the concentration of essential fatty acids to values comparable with those of control subjects, but 500 mL 20% Intralipid once a week was sufficient to prevent an increase in the Holman index above 0.2.
Similar articles
-
Deficiencies of essential fatty acids, vitamin A and E and changes in plasma lipoproteins in patients with reduced fat absorption or intestinal failure.Eur J Clin Nutr. 2000 Aug;54(8):632-42. doi: 10.1038/sj.ejcn.1601067. Eur J Clin Nutr. 2000. PMID: 10951512
-
No Clinical or Biochemical Evidence for Essential Fatty Acid Deficiency in Home Patients Who Depend on Long-Term Mixed Olive Oil- and Soybean Oil-Based Parenteral Nutrition.JPEN J Parenter Enteral Nutr. 2016 Sep;40(7):982-8. doi: 10.1177/0148607115581375. Epub 2015 Apr 17. JPEN J Parenter Enteral Nutr. 2016. PMID: 25888677
-
Effect of changing the lipid component of home parenteral nutrition in adults.Clin Nutr. 2019 Jun;38(3):1355-1361. doi: 10.1016/j.clnu.2018.05.028. Epub 2018 Jun 6. Clin Nutr. 2019. PMID: 29907355
-
Intravenous lipids in home parenteral nutrition.World Rev Nutr Diet. 2015;112:141-9. doi: 10.1159/000365608. Epub 2014 Nov 24. World Rev Nutr Diet. 2015. PMID: 25471810 Review.
-
The effects of different parenteral nutrition lipid formulations on clinical and laboratory endpoints in patients receiving home parenteral nutrition: A systematic review.Clin Nutr. 2022 Jan;41(1):80-90. doi: 10.1016/j.clnu.2021.11.009. Epub 2021 Nov 14. Clin Nutr. 2022. PMID: 34864457
Cited by
-
Metabolic and catheter complications of parenteral nutrition.Curr Gastroenterol Rep. 2004 Aug;6(4):327-34. doi: 10.1007/s11894-004-0086-2. Curr Gastroenterol Rep. 2004. PMID: 15245703 Review.
-
Fish oil prevents essential fatty acid deficiency and enhances growth: clinical and biochemical implications.Metabolism. 2008 May;57(5):698-707. doi: 10.1016/j.metabol.2008.01.008. Metabolism. 2008. PMID: 18442636 Free PMC article.
-
Polyphenolic Antioxidants in Lipid Emulsions: Partitioning Effects and Interfacial Phenomena.Foods. 2021 Mar 5;10(3):539. doi: 10.3390/foods10030539. Foods. 2021. PMID: 33807705 Free PMC article. Review.
-
Home parenteral nutrition with an omega-3-fatty-acid-enriched MCT/LCT lipid emulsion in patients with chronic intestinal failure (the HOME study): study protocol for a randomized, controlled, multicenter, international clinical trial.Trials. 2019 Dec 30;20(1):808. doi: 10.1186/s13063-019-3994-z. Trials. 2019. PMID: 31888740 Free PMC article.
-
The essentiality of arachidonic acid and docosahexaenoic acid.Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):165-70. doi: 10.1016/j.plefa.2009.05.020. Epub 2009 Jun 18. Prostaglandins Leukot Essent Fatty Acids. 2009. PMID: 19540099 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources